glp 1 drugs and anxiety The risk of depression, anxiety, suicidal behavior in patients with obesity on glucagon like peptide-1 receptor agonist therapy GLP-1 drugs linked to less

While GLP-1 medications offer several benefits, they also come with limitations and downsides that patients and healthcare providers need to consider

For example, someone who begins a GLP-1 medication in January may notice increased shedding in March or April

Buyers who want to evaluate supplement options while that equation is still favorable are better positioned to do that now than after the prescription landscape reshapes the category further

Studies that were analyzed evaluated the effects of these agents on anxiety, depression, psychosocial functioning in schizophrenia, dementia, cognitive functioning, substance use disorders such as cocaine and alcohol, and behavioral problems in autism

There was a French study about a year ago that showed increased risk specifically in papillary thyroid cancer, which is the most common differentiated thyroid cancer